Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Rubens

Showing results (151-160 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer & Clinical Oncology|November 1, 1983
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerR Steiner, J F Stewart, B M Cantwell, et al.
Clinical Oncology|December 1, 1979
Relation between endocrine function and survival of patients with breast cancer after hypophysectomyD Y Wang, R D Bulbrook, R D Rubens, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of dexamethasone dose on the control of chemotherapy-induced nausea and vomitingR E Coleman, C J Twelves, S M O'Reilly, et al.
European Journal of Cancer|April 1, 1981
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancerJ F Stewart, R J King, S A Sexton, et al.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1988
Osteocalcin: a potential marker of metastatic bone disease and response to treatmentR E Coleman, G Mashiter, I Fogelman, et al.
Pageof 22

Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer & Clinical Oncology|November 1, 1983
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerR Steiner, J F Stewart, B M Cantwell, et al.
Clinical Oncology|December 1, 1979
Relation between endocrine function and survival of patients with breast cancer after hypophysectomyD Y Wang, R D Bulbrook, R D Rubens, et al.
British Journal of Cancer|May 1, 1992
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone diseaseR E Coleman, S Houston, I James, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II studyJ Carmo-Pereira, F O Costa, D W Miles, et al.
British Journal of Cancer|March 31, 1999
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancerS J Houston, T A Plunkett, D M Barnes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of dexamethasone dose on the control of chemotherapy-induced nausea and vomitingR E Coleman, C J Twelves, S M O'Reilly, et al.
European Journal of Cancer|April 1, 1981
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancerJ F Stewart, R J King, S A Sexton, et al.
Lancet (London, England)|June 30, 1990
Reconstitution of interleukin 2 with albumin for infusionD W Miles, C R Bird, M Wadhwa, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1988
Osteocalcin: a potential marker of metastatic bone disease and response to treatmentR E Coleman, G Mashiter, I Fogelman, et al.
Pageof 22